Trogenix
Trogenix is a gene therapy platform founded in 2023 by Steve Pollard.
B2X
Country
Email Address
Founded Date
2023
Founder
Headquarters
Latest Funding Round Date
October 6, 2025
Latest Funding Round Amount (USD)
95,000,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
95,000,000
Official Website
Find more companies like Trogenix
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.